<SEC-DOCUMENT>0001193125-26-210299.txt : 20260507
<SEC-HEADER>0001193125-26-210299.hdr.sgml : 20260507
<ACCEPTANCE-DATETIME>20260507070611
ACCESSION NUMBER:		0001193125-26-210299
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		11
CONFORMED PERIOD OF REPORT:	20260507
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260507
DATE AS OF CHANGE:		20260507

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Beam Therapeutics Inc.
		CENTRAL INDEX KEY:			0001745999
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39208
		FILM NUMBER:		26950815

	BUSINESS ADDRESS:	
		STREET 1:		26 LANDSDOWNE STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
		BUSINESS PHONE:		857-327-8775

	MAIL ADDRESS:	
		STREET 1:		26 LANDSDOWNE STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>beam-20260507.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2026-05-07T06:18:17.2592+00:00 -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:beam="http://beamtx.com/20260507" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:utr="http://www.xbrl.org/2009/utr">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_d5693ca9-7449-473a-b137-831763bbf72a" name="dei:AmendmentFlag" contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c">false</ix:nonNumeric><ix:nonNumeric id="F_26fd542b-bc60-4467-88f2-98a3bf39340a" name="dei:EntityCentralIndexKey" contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c">0001745999</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="beam-20260507.xsd"/></ix:references><ix:resources><xbrli:context id="C_cab538a3-c540-47ba-9128-c8b2986ed13c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001745999</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-05-07</xbrli:startDate><xbrli:endDate>2026-05-07</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.8in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1.5pt double;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:16pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:16pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Washington, D.C. 20549</span></p><p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:16pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM </span><span style="font-size:16pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c8da760d-d292-4d3f-a371-919ecff28c03" contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:16pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8-K</span></ix:nonNumeric></span></p><p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CURRENT REPORT</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span style="font-size:11pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f07d9c18-c14c-4c63-af7b-359b8edd99b6" contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">May 7, 2026</span></ix:nonNumeric></span></p><p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:22pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3e8a56a1-8d20-4f64-aa40-0ef2659fab7a" contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:22pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">BEAM THERAPEUTICS INC.</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Exact name of registrant as specified in its charter)</span></p><p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:33%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:32%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:33%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8pt;"><ix:nonNumeric id="F_dabbd1ec-46d4-46f4-af61-c2e4b4c87bb5" contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="margin-left:1.667%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="margin-left:1.667%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8pt;"><ix:nonNumeric id="F_8dfacb8d-1242-41cf-8208-3c8e42cd8d32" contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">001-39208</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8pt;"><ix:nonNumeric id="F_bd5041e1-b408-47f2-8d0c-83e6a3413a39" contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">81-5238376</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(State or other jurisdiction</span></p></td>
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.667%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.667%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Commission</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(IRS Employer</span></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">of incorporation)</span></p></td>
     <td style="padding-top:0in;text-indent:8pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.48%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;text-indent:8pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.48%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">File Number)</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Identification No.)</span></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;text-indent:8pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.48%;text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;text-indent:8pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.48%;text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8pt;"><ix:nonNumeric id="F_4ead2979-ac4d-468c-a616-4ad4afd1a8fb" contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">238 Main Street</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8pt;"><ix:nonNumeric id="F_05a2b5a6-13c8-41e1-b5de-c4544f8f7300" contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cambridge</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:8pt;"><ix:nonNumeric id="F_ddf0f63a-08a8-41ce-9fcc-949ea1c214d0" contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c" name="dei:EntityAddressStateOrProvince"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">MA</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8pt;"><ix:nonNumeric id="F_5722a4f9-8ffa-4e30-bc3d-bc54b55eef75" contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">02142</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Address of principal executive offices)</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Zip Code)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Registrant&#8217;s telephone number, including area code): (</span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3b10691e-fd17-472b-aca6-99f28051025c" contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">857</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) </span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6d72273e-817b-4bc6-959b-dc63519424d4" contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">327-8775</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not Applicable</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Former name or former address, if changed since last report)</span></p><p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.593%;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:5%;box-sizing:content-box;"/>
     <td style="width:95%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.593%;text-align:left;"><span style="font-size:9pt;"><ix:nonNumeric id="F_b0e3173c-0e53-4ef1-ac2c-cf604580d077" contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c" name="dei:WrittenCommunications" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.593%;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:5%;box-sizing:content-box;"/>
     <td style="width:95%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.593%;text-align:left;"><span style="font-size:9pt;"><ix:nonNumeric id="F_76e81b34-389b-4f77-9596-cd101b3e7dfd" contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c" name="dei:SolicitingMaterial" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.593%;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:5%;box-sizing:content-box;"/>
     <td style="width:95%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.593%;text-align:left;"><span style="font-size:9pt;"><ix:nonNumeric id="F_9d03e2e1-f882-4b10-88ce-8ce2c651dbe1" contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.593%;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:5%;box-sizing:content-box;"/>
     <td style="width:95%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.593%;text-align:left;"><span style="font-size:9pt;"><ix:nonNumeric id="F_ce9be51b-b2a0-4a53-93c0-17d824ce1342" contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.593%;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:34.84%;box-sizing:content-box;"/>
     <td style="width:33.64%;box-sizing:content-box;"/>
     <td style="width:31.52%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="border-top:0.5pt solid;padding-top:0in;border-right:0.5pt solid;border-left:0.5pt solid;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Title of each class</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="border-top:0.5pt solid;padding-top:0in;border-right:0.5pt solid;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Trading</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Symbol(s)</span></p></td>
     <td style="border-top:0.5pt solid;padding-top:0in;border-right:0.5pt solid;padding-left:0.1in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name of each exchange</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">on which registered</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;border-right:0.5pt solid;border-left:0.5pt solid;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_f75a21d5-2169-4b35-9ffc-7606775581ff" contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Common Stock, par value $0.01 per share</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_d504734e-39cc-4ca7-892d-7a94aea865d6" contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">BEAM</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_5811ea91-dbc2-49c0-9ac0-166e0431a94d" contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Nasdaq Global Select Market</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Emerging growth company </span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_86c79b6a-cbed-41d2-b469-2a7018062a79" contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1.5pt double;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.8in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.8in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 2.02 Results of Operations and Financial Condition.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 7, 2026, the Company issued a press release announcing its financial results for the quarter ended March 31, 2026. A copy of this press release is furnished as Exhibit 99.1 and is incorporated herein by reference.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information in this Item 2.02 as well as in the accompanying Exhibit 99.1 attached hereto is being furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing by the Company, under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9.01 Financial Statements and Exhibits.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d) Exhibits</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:8.72%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:90.28%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit No.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="beam-ex99_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Press Release Issued by Beam Therapeutics Inc. on May 7, 2026</span></a></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.8in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.8in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNATURES</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:47.99%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:7.001%;box-sizing:content-box;"/>
     <td style="width:44.009%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">BEAM THERAPEUTICS INC.</span></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: May 7, 2026</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.75pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ John Evans</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">John Evans</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Title:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Executive Officer</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.8in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>beam-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!-- DFIN ActiveDisclosure (SM) HTML Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2026-05-07T06:18:17.2998+00:00 --><!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 99.1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><img src="img55885398_0.jpg" alt="img55885398_0.jpg" style="width:152px;height:72px;"></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Beam Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recent BEAM-302 Topline Data in Alpha-1 Antitrypsin Deficiency (AATD) Demonstrate Strong Single-dose Safety and Efficacy Profile, with 60 mg Selected as Optimal Biological Dose; Global Pivotal Cohort Expected to Initiate in Second Half of 2026</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Data from Phase 1/2 BEACON Clinical Trial of Risto-cel in Sickle Cell Disease Published in April 1 Issue of the New England Journal of Medicine; U.S. Biologics License Application (BLA) Submission Expected as Early as Year-End 2026</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investigational New Drug (IND) Application for BEAM-304 in PKU and Data from BEAM-301 in GSDIa Anticipated in 2026</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Ended First Quarter 2026 with $1.2 Billion in Cash, Cash Equivalents and Marketable Securities; Cash Runway Expected to Support Operating Plans into mid-2029</font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cambridge, Mass., May 7, 2026 </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x2013; Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today reported first quarter 2026 financial results and provided updates across the company&#x2019;s hematology and genetic disease franchises.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;The first quarter of 2026 was a defining period for Beam, marked by meaningful clinical advances across our portfolio and key steps toward becoming a commercial-stage company. The updated topline data from BEAM-302 &#x2013; including robust increases in total AAT and a well-tolerated safety profile &#x2013; give us high confidence in the 60 mg optimal biological dose and a clear path to initiating the pivotal cohort in the second half of this year,&#x201d; said John Evans, chief executive officer of Beam Therapeutics. &#x201c;Publication of the BEACON trial data in the </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">New England Journal of Medicine</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> underscores the differentiated profile of risto-cel, and we remain on track to submit our BLA as early as year-end 2026, a milestone toward bringing a potentially transformative treatment to patients with sickle cell disease. With BEAM-304 in PKU, we are extending the reach of our clinically validated base editing platform to directly correct disease-causing mutations in a new indication, further demonstrating the breadth of what precision genetic medicine can achieve. With a strong cash position extending our runway into mid-2029, we have the financial foundation to execute across all of these priorities and deliver on our mission to bring precision genetic medicines to patients who need them most.&#x201d;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">First Quarter 2026 and Recent Progress and Anticipated Milestones</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Corporate</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Beam Therapeutics has been selected for the </font><font><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TIME100 Most Influential Companies list</font></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> by TIME Magazine, highlighting 100 companies making an extraordinary impact around the world. In February, John Evans, chief executive officer of Beam, was recognized as part of the </font><font><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TIME100 Health list</font></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, TIME&#x2019;s list honoring leaders who are advancing care, shaping policy and driving innovations that transform lives. </font></div></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Liver-targeted Genetic Disease Franchise</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">BEAM-302: </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Beam&#x2019;s lead genetic disease program is designed to be a best-in-class and first-in-class liver-targeting therapy for alpha-1 antitrypsin deficiency (AATD) that addresses the underlying pathophysiology of both liver and lung disease.</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In March, Beam </font><font><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">announced</font></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> updated safety and efficacy data from the ongoing Phase 1/2 trial of BEAM-302. Treatment with BEAM-302 led to rapid and durable increases of total and functional AAT, decreases in mutant Z-AAT, and new production of corrected M-AAT, with a well-tolerated safety profile across single doses up to 75 mg. </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.3in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amy Simon, M.D., chief medical officer of Beam, will give a </font><font><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">presentation</font></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> on translating scientific discovery in gene editing to clinical progress for patients with lung disease, featuring the recent clinical data from the BEAM-302 trial, at the upcoming American Thoracic Society (ATS) International Conference 2026, being held in Orlando, Florida, May 15-20. The presentation will be included in the scientific symposium titled &#x201c;Rewriting the Code: Precision Delivery Vectors and Gene Therapy for Pulmonary Vascular Diseases&#x201d; at 3:30 p.m. ET on Monday, May 18, 2026.</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on feedback from the U.S. Food and Drug Administration (FDA), Beam intends to pursue an accelerated approval pathway for BEAM-302. To support a future biologics licensing application (BLA) submission, the company anticipates enrolling approximately 50 additional patients with AATD-associated lung disease, with or without liver disease, in an expansion of the ongoing open-label Phase 1/2 trial. Beam expects to initiate this pivotal cohort in the second half of 2026.</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, Beam expects to present detailed and updated BEAM-302 data at a medical congress in 2026.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">BEAM-304: </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">BEAM-304 leverages Beam&#x2019;s proprietary and clinically validated base editing technology and lipid nanoparticle (LNP) delivery capabilities to directly and durably correct mutations in the phenylalanine hydroxylase (</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">PAH</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) gene that cause phenylketonuria (PKU).</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A planned Phase 1/2 trial will initially evaluate safety, tolerability, and reduction of blood Phe levels in PKU patients with the R408W mutation, followed thereafter by a base editor for a second mutation, with a goal of establishing clinical proof of concept for base editing in PKU.</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Beam expects to file an investigational new drug (IND) application with the FDA for BEAM-304 in 2026 following completion of pre-IND activities. </font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">BEAM-301: </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">BEAM-301 aims to correct the most common disease-causing mutation, R83C, in patients with glycogen storage disease type Ia (GSDIa).</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">BEAM-301 is currently being evaluated in an open-label Phase 1/2 dose-exploration trial in patients with GSDIa. </font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Beam expects to report initial clinical data in 2026.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Hematology Franchise</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risto-cel: </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Ristoglogene autogetemcel (risto-cel, formerly known as BEAM-101) is an investigational autologous cell therapy with a potential best-in-class profile for the treatment of sickle cell disease (SCD).</font></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Data from the ongoing Phase 1/2 BEACON clinical trial evaluating risto-cel for the treatment of SCD with severe vaso-occlusive crises (VOCs) were </font><font><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">published</font></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in </font><font><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The New England Journal of Medicine</font></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Data demonstrate risto-cel&#x2019;s differentiated profile, including deep resolution of SCD markers, rapid engraftment, reduced hospitalization, and a predictable manufacturing process that may improve patient experience and treatment center capacity and reduce the length of the transplant process.</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Beam expects to submit a BLA for risto-cel as early as year-end 2026.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Next-generation Programs in Sickle Cell Disease and Hematology:</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The ongoing Phase 1 healthy volunteer clinical trial of BEAM-103, an anti-CD117 monoclonal antibody that enables ESCAPE, is expected to complete dosing in the first half of 2026.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">First Quarter 2026 Financial Results</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash Position:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Cash, cash equivalents and marketable securities were $1.2 billion as of March 31, 2026, compared to $1.2 billion as of December 31, 2025. </font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research &amp; Development (R&amp;D) Expenses: </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">R&amp;D expenses were $104.5 million for the first quarter of 2026, compared to $98.8 million for the first quarter of 2025.</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General &amp; Administrative (G&amp;A) Expenses</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: G&amp;A expenses were $34.4 million for the first quarter of 2026, compared to $27.9 million for the first quarter of 2025. </font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net Income (Loss):</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Net loss was $94.3 million, or $0.91 per share, for the first quarter of 2026, compared to net losses of $108.3 million, or $1.23 per share, for the first quarter of 2025. </font></div></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash Runway</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Beam expects that its cash, cash equivalents and marketable securities as of March 31, 2026, which includes $100 million from the close of the company&#x2019;s financing </font><font><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">agreement</font></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> with Sixth Street, along with an anticipated additional $100 million from the Sixth Street facility, will fund anticipated operating expenses and capital expenditure requirements into mid-2029, funding the company through the anticipated launch of risto-cel in SCD, execution of the BEAM-302 pivotal development plan in AATD, and clinical proof of concept for BEAM-304 in PKU.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.3in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">About Beam Therapeutics</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Beam Therapeutics (Nasdaq: BEAM) is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform with integrated gene editing, delivery and internal manufacturing capabilities. Beam&#x2019;s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing lifelong cures to patients suffering from serious diseases.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cautionary Note Regarding Forward-Looking Statements</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Investors are cautioned not to place undue reliance on these forward-looking statements, including, but not limited to, statements related to: the therapeutic applications and potential of our technology, including with respect to SCD, AATD, PKU, ESCAPE and GSDIa; our plans, and anticipated timing, to advance our programs and present data from ongoing clinical trials; the clinical trial designs and expectations for risto-cel, BEAM-103, BEAM-301, BEAM-302 and BEAM-304; our planned submission of a BLA for risto-cel; our expected presentations at upcoming medical conferences, including at ATS 2026; our anticipated regulatory interactions and filings; the sufficiency of our capital resources to fund operating expenses and capital expenditure requirements and the period in which such resources are expected to be available; and our ability to develop lifelong, curative, precision genetic medicines for patients through base editing. Each forward-looking statement is subject to important risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statement, including, without limitation, risks and uncertainties related to: our ability to develop, obtain regulatory approval for, and commercialize our product candidates, which may take longer or cost more than planned; our ability to raise additional funding, which may not be available; our ability to obtain, maintain and enforce patent and other intellectual property protection for our product candidates; the uncertainty that our product candidates will receive regulatory approval necessary to initiate or continue human clinical trials; that preclinical testing of our product candidates and preliminary or interim data from preclinical studies and clinical trials may not be predictive of the results or success of ongoing or later clinical trials; that initiation and enrollment of, and anticipated timing to advance, our clinical trials may take longer than expected; that our product candidates, including the delivery modalities we rely on to administer them, may cause serious adverse events; that our product candidates may experience manufacturing or supply interruptions or failures; risks related to competitive products; and the other risks and uncertainties identified under the headings &#x201c;Risk Factors Summary&#x201d; and &#x201c;Risk Factors&#x201d; in our Annual Report on Form 10-K for the year ended December 31, 2025, and in any subsequent filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date of this press release. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by applicable law.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Contacts:</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Investors:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Holly Manning</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Beam Therapeutics</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0563c1;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">hmanning@beamtx.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Media:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Josie Butler</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1AB</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0563c1;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">josie@1abmedia.com</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.3in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:67.313%;box-sizing:content-box;"></td>
     <td style="width:1.5%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:12.843%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:1.5%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:12.843%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="8" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Condensed Consolidated Balance Sheet Data (unaudited)</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="8" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(in thousands)</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">March 31,<br>2026</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,<br>2025</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash, cash equivalents, and marketable securities</font></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,211,652</font></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,245,210</font></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets</font></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,480,798</font></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,481,177</font></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities</font></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">316,360</font></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">242,819</font></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stockholders&#x2019; equity</font></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,164,438</font></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,238,358</font></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:59.52%;box-sizing:content-box;"></td>
     <td style="width:1.68%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:16.56%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:1.68%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:16.56%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Condensed Consolidated Statement of Operations (unaudited)</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(in thousands, except share and per share data)</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended March 31,</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2026</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">License and collaboration revenue</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31,738</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,470</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating expenses:</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104,524</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">98,816</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">34,429</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,940</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating expenses</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">138,953</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">126,756</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss from operations</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(107,215</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(119,286</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income (expense):</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of derivative liabilities</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,500</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,200</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of non-controlling equity investments</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(2,081</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of contingent consideration liabilities</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">514</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(27</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest and other income (expense), net</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,867</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,864</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total other income (expense)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,897</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,956</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</font></p></td>
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(94,318</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(108,330</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrealized gain (loss) on marketable securities</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(2,181</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(519</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Comprehensive loss</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(96,499</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(108,849</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss per common share, basic and diluted</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(0.91</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(1.23</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;">
     <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average common shares outstanding, basic and diluted</font></p></td>
     <td style="background-color:#ffffff;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">103,262,001</font></p></td>
     <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">87,975,311</font></p></td>
     <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.3in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img55885398_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img55885398_0.jpg
M_]C_X  02D9)1@ ! @$ D "0  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #V @8# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&<%4YJ]&?LZGNQ?-*5*-6$8^]*21]%T445_3)\N%%%% !1110 4444 %%%%
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M.^*^RZ\N^,W@!OBA\.==\#),MLVN7&@*;HE0;6*Q\1Z1J5S<H6!R\-K9S.J
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MPNDWLZ/'>D9.[2[S;&ETVT;FMG2&[7YML,L<;35Q/[4WC0:!X)M/#5M-LO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6E.,X?=]%%%?Z9GY*%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MSQ=:.':EHU]7A*%!)K1I4TFMPHHHK]C/""BBB@ HHHH **** "BBB@ HHHH
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MCS\#[Z-/A=XMUA=,\X2W/@V[BE\0>%K_ '$M,9?#]P)8+::X/$NH:4VGZHP
M"WR\5^WW[/O_  4)B^(GV'1?BM\(O'_@/7IO+A_X2/P]X2\4^)_!%Y,QV[Y5
MM--N=>T 2N5"13V^LV4,>Z:[UF% <?I'#!#;H(K>&*"->D<,:1(.W"(%4< #
M@5+5X_-L'C[N65PIU7_R_AB'&K?O+EH1C/\ [?C*W2QY7AKX(<=^&CHT,O\
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MD1MXQM_%ER8@O[L&6XEGV<F8R?/5*C-ZV2]=/P2;^\'.*\_0_M@HK^-#P/\
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MGP2\=Z'^TG\+=#M]%^'GQ:UB?1O'.A:7;);:5X9^)QMKC4XM1L;:!$@LM/\
M'6FVNHZ@]I"@BMM>T?6;C>B:Q9VL%TZO,^66[V:_)DRC;5;=3ZS_ &;O^"QM
MOX<_8!\8^*_BE=0^+/VB?@Y?:'\,_#>G:I<N;GXGWOBC3]3E^'WBG69%DCO+
MA=,L= U]O'MU%*+J]3PO]L:^AUCQ78Q#^:OXK_%CXA?'#Q_XC^)_Q1\3ZCXN
M\:^*KY[[5M8U&3<W/RV]C8VR!+73-)TZ )9Z5I-A%;Z?IME%#:6=O#!$B#SO
M_/\ G\S7[S_\$3OV%M#^-_C76OVE?BMH5MK7PZ^%>L1:+X%\/ZK:I<Z5XI^)
M:6]OJ4^I:A:SH\-]I7@>PNM/O$M)8VM[WQ!JNF2,\D>BW]G<7:--2E;=_/6V
MB\KZ_P##"NY67;^KO^OS/E/]FC_@D?\ M@_M*Z+IWC"S\,Z-\*O >JQ1W6E^
M*?BO>7^@2:S8R(LL=YHGAC3],U;Q3>6ES"\<VGZC=Z3INC:E%(DUEJDT.Z1?
MM/4/^#>KX[1:<)=*^/OPEO=7\MR;'4-&\8Z9IPE _=H-4MK'5[DQLV \IT=6
M0?,(9#\I_K"HK!UIWTLEVM<M0CUU/\^;]J#]AW]I+]D+4;:#XS> I['P_J-P
M;71?'OAZX7Q!X$UJX =EMK;Q!:1JMAJ$B132Q:-KUMH^MRV\4ERFFFV7S:\#
M^&7Q,\=?!SQYX9^)?PV\1ZAX4\:^$=3@U70]:TV79-!<1$B2WN(F#07VG7T#
M2V6J:9>1SV&IZ?<7-A?6\]I<30O_ *+_ ,2/ASX*^+G@;Q/\-_B)X>T_Q3X,
M\8:5<Z-KVB:E"LMO=6ERN!)$W$MI?6<PBO--U&U>&^TS4+>VO[&>"[MH9D_@
M _;#_9OUO]D[]HCXB_!+5YI[^S\-:HEYX3UR=%1O$/@K6H4U/PMK+^6JP&[E
MTNXBM=7CMP8+37+/4[%&/V4UM3J<Z:=KK[FOZW^1$H\NJV_%,_MM_84_:Z\.
M?MG_ +/_ (=^*VFPVND^*[.5O#'Q+\+6TK.OAOQQIEO;2:A%:K*\DYT76+>Y
MM==T"6629QIFH165S<2:C8WZQ_9%?R ?\$%/C5=^"_VH_%GP:NKQQH/QH\!:
MA/9V!D(C?QI\/%F\1:7=)&Q*@KX3E\;1S^6%DES;,[%+8+7]?]<]2/+)I;;K
MT?\ EL:1=U?Y/U"BBBH*"BBB@ HHHH @7J/J/YU/4"]1]1_.IZ "BBB@ HHH
MH AN+>WN[>>UNH(;FUN89;>YMKB))K>XMYD:.:">&16CEAEC9HY8I%9)$9D=
M2I(++.SM-/M8+*PM;:QLK6-8;:TLX(K:UMX4&$B@MX52*&-!PL<:*JC@ 59K
M\M_VJ_\ @H9XI_9O^+&J_#"+X.Z;K<-MI.BZSH_B6^\97=HFL:?JUDLCW']D
M0>&F-HMGJ<.IZ6RC5+H2OI[3B2/S?)BZL)@\3CJCH8:"J5%%U'%SA!<L6HMW
MJ2BFUS+1-RM=I63/CN->..%O#W*H<0\68V>79=/%T<LABZ678_,)_6<3"M7H
MT)0R["XJM2IU%AJC52K&&']I&%.515:E*,_U(HK^?G4O^"O/QFEW?V/\,?AC
M8]=IU(^*]5"X.,M]FUW1=^.IVE,CGBO2O@C^UK^W[^T[K36'PW\+?#+0]#MK
MA(=:\:S^$M9MO"F@!@K.DVH:OK^LO?WZ1LKII&F0W^I.K)*]O':[[F/T9\/Y
MA2IRK5_J^'IQ5Y3JXB"2736'/=O9)7;>B3;1^3X#Z3_AEG698;)^'(<5<29G
MC)JGA<%DW#>+JUZTMVXPQ4\(XTX1O.K5J<E*C34JE:<(1E)?MY17'>!=%\5Z
M%X>M++QMXSD\=>)"!+J6N#0M)\-V+3LJAX-*T?2H1]CT^,J3"E_?:K?EF=I;
M]T,<478UXLDDVE)22=E*/-9^:YE&5GYQ3[H_H+#59U\/1K5<-7P=2K3A.>%Q
M+P\L1AY22;HUI82OBL,ZD'[LW0Q%>E=/DJ35FRBBBD;A7\6?_!<K_D_'7/\
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MVN?^"F__ /D>C_A&/$O_ $+VN?\ @IO_ /Y'K6$.163;UOJ2VY.]NEOZ^_\
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M^+G_ *<OA]6M'XUZ,F?POY?FC\D/^"<'_)]?[+?_ &5SPY_Z%-7]_%?P#_\
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M-?\ !OA^SE9O"_BWXV?&?Q L;(TT6A1>"?"\<X5@6C)O/#WBF6..0#:VR7S
MI.R16PP7M::V_"+7Z(.67]/_ (/DON/Y*J_;;_@G/_P2,^('[0NL^'_BU^T%
MHFK_  _^ MI<6VJ6>@:G%<Z1XQ^*\<3K/!9:=92"'4- \&WH"F_\37*VUYJE
MA((/"J2_:VU_2/Z.?@5_P3A_8S_9WN++5? 'P2\-WGBBP:.:W\9>.#<^//$\
M%Y'C9?Z=>^*)M1M= O  !YOAJRT90"VU 9)"_P!PUG.LWI%6\WO\EJEZZ_(I
M0[OY?YW*&E:5IFAZ7INB:+I]GI6CZ/86>E:3I>G6T5GI^FZ9I]O':6&GV-I
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M2=.K7R!X"@XT<NS7$\U#+X8FG"53,85/[2=6M/"XNCA?O[PCX5T+P-X7\/\
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MUZ;PQXR\8QZ+KEO;VUU-8MH?B6^*07D?FVTGVC3-&O;1O,C.[:LY=>CJK<4
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M<J77?^OZ:"S[?U_37WGL%%9&OZ]I/A?1=2\0Z]>IIVC:/:2WVI7TD<TJ6MI
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M*O"WAKQ1;Q-!!XDT#1M>A@9MS0PZQIUMJ$<3-@;FC2X5"V!DC.!G%?G/\,_
M_A'QY^UW\>=+\9>'],\1Z?:0^(+^VL]4MQ<00WJ>(]!MUN8T)&V58+B>(-_<
ME<=Z_2#P]HMIX;T#0_#MAO\ L&@:/IFBV7F$%_LFE64-C;;R  7\F!-Q  SG
M Q7Y264/QEF_:F^-R_!*ZTNT\2"ZUUM3?5ETMH&T/^VM)$J1C5;>Y@\[[>;
M@QHLNP/AMF\%2T<+ZOR^0H]=;:;WMU1^@_\ PSC\"O\ HEOA#_P6)_\ %5TW
MA3X1_#3P-J<FL^$/!6@^'M4EM);"2^TRS6WN'LYY89I;9G#',4DMM!(R]VB0
M]J^1/L/_  4 _P"@SX+_ ._7@W_Y55[A\#[?]I"'5=</QPOM"N]*;3[8:&ND
M)H:R)J N2;EIO[)L[:0H;; 7S69-WW0&YJDU?X6OE;^ME^ .]M97\N:_;^OE
MZ'4?M%_\D,^*?_8FZO\ ^B*X/]C+_DW;P/\ ]?7BS_U+M<KO/VB_^2&?%/\
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MVK,H(#-!8001,P#-ABI;D\\FMNBJLNW]?TD3=]PK\U?A+XI\,>$_VP/CW?\
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M-T&1+CP_X4MYAAI':"RT^)(W4&.;^R- L8K?4IH@L,^IZFS0L6AN8T]5T?\
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>BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>beam-20260507.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2026-05-07T06:18:17.5177+00:00 -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://beamtx.com/20260507" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:beam="http://beamtx.com/20260507" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" namespace="http://fasb.org/us-gaap/2025"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" namespace="http://xbrl.sec.gov/dei/2025"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://beamtx.com/20260507/taxonomy/role/Role_DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>75000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:roleRef roleURI="http://beamtx.com/20260507/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:href="beam-20260507.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://beamtx.com/20260507/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="49.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="50.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="51.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="52.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="53.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="54.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="55.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="56.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="57.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="58.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="59.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="60.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="61.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="62.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="63.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="64.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="65.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="66.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="67.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="68.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="69.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="70.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 07, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  07,  2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BEAM THERAPEUTICS INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001745999<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39208<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">81-5238376<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">238 Main Street<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cambridge<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">327-8775<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BEAM<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="beam-20260507.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>75000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://beamtx.com/20260507/taxonomy/role/Role_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="beam-20260507.htm">beam-20260507.htm</File>
    <File>beam-20260507.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>12
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "beam-20260507.htm": {
   "nsprefix": "beam",
   "nsuri": "http://beamtx.com/20260507",
   "dts": {
    "inline": {
     "local": [
      "beam-20260507.htm"
     ]
    },
    "schema": {
     "local": [
      "beam-20260507.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://beamtx.com/20260507/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
     "longName": "75000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_cab538a3-c540-47ba-9128-c8b2986ed13c",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "beam-20260507.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_cab538a3-c540-47ba-9128-c8b2986ed13c",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "beam-20260507.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://beamtx.com/20260507/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://beamtx.com/20260507/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://beamtx.com/20260507/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://beamtx.com/20260507/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://beamtx.com/20260507/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://beamtx.com/20260507/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://beamtx.com/20260507/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://beamtx.com/20260507/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://beamtx.com/20260507/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://beamtx.com/20260507/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://beamtx.com/20260507/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://beamtx.com/20260507/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation State Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://beamtx.com/20260507/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://beamtx.com/20260507/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://beamtx.com/20260507/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://beamtx.com/20260507/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://beamtx.com/20260507/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre Commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://beamtx.com/20260507/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security 12b Title",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://beamtx.com/20260507/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://beamtx.com/20260507/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://beamtx.com/20260507/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://beamtx.com/20260507/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>13
<FILENAME>0001193125-26-210299-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-26-210299-xbrl.zip
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M,&5=T57,P0 ^"QZ[BPN&@J,'V7/ C[4Y'MD\FN>?%]FA@SV0@($<VCNKB%%
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M/5PWK+$.[<0YM"F@!IO#*(&=5S2 ^4IT.2;@+@#U3<  6<2(B6M0M!A!@]O
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MFS^809E3]J-(50)^$F=[9__Z==]OZ'A]^TB!%,SF37!O\^;& [FTUBY$G!$
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M'?"DL+%6H#=K3MV.Z+_5ZK94_F&A#K]8H<87<X9!88SDNQ?=%RL!$#'.?;;
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MQM__/U!+ 0(4 Q0    ( ,0XIUSD=AP@L10  "W?   1              "
M 0    !B96%M+3(P,C8P-3 W+FAT;5!+ 0(4 Q0    ( ,0XIUR;N9>J1@D
M )1S   1              "  > 4  !B96%M+3(P,C8P-3 W+GAS9%!+ 0(4
M Q0    ( ,0XIUQ_<M4FC"(  $?X 0 /              "  54>  !B96%M
A+65X.3E?,2YH=&U02P4&      ,  P"[    #D$

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>beam-20260507_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="beam-20260507.xsd" xlink:type="simple"/>
    <context id="C_cab538a3-c540-47ba-9128-c8b2986ed13c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001745999</identifier>
        </entity>
        <period>
            <startDate>2026-05-07</startDate>
            <endDate>2026-05-07</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c"
      id="F_d5693ca9-7449-473a-b137-831763bbf72a">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c"
      id="F_26fd542b-bc60-4467-88f2-98a3bf39340a">0001745999</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c"
      id="F_c8da760d-d292-4d3f-a371-919ecff28c03">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c"
      id="F_f07d9c18-c14c-4c63-af7b-359b8edd99b6">2026-05-07</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c"
      id="F_3e8a56a1-8d20-4f64-aa40-0ef2659fab7a">BEAM THERAPEUTICS INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c"
      id="F_dabbd1ec-46d4-46f4-af61-c2e4b4c87bb5">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c"
      id="F_8dfacb8d-1242-41cf-8208-3c8e42cd8d32">001-39208</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c"
      id="F_bd5041e1-b408-47f2-8d0c-83e6a3413a39">81-5238376</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c"
      id="F_4ead2979-ac4d-468c-a616-4ad4afd1a8fb">238 Main Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c"
      id="F_05a2b5a6-13c8-41e1-b5de-c4544f8f7300">Cambridge</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c"
      id="F_ddf0f63a-08a8-41ce-9fcc-949ea1c214d0">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c"
      id="F_5722a4f9-8ffa-4e30-bc3d-bc54b55eef75">02142</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c"
      id="F_3b10691e-fd17-472b-aca6-99f28051025c">857</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c"
      id="F_6d72273e-817b-4bc6-959b-dc63519424d4">327-8775</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c"
      id="F_b0e3173c-0e53-4ef1-ac2c-cf604580d077">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c"
      id="F_76e81b34-389b-4f77-9596-cd101b3e7dfd">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c"
      id="F_9d03e2e1-f882-4b10-88ce-8ce2c651dbe1">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c"
      id="F_ce9be51b-b2a0-4a53-93c0-17d824ce1342">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c"
      id="F_f75a21d5-2169-4b35-9ffc-7606775581ff">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c"
      id="F_d504734e-39cc-4ca7-892d-7a94aea865d6">BEAM</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c"
      id="F_5811ea91-dbc2-49c0-9ac0-166e0431a94d">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_cab538a3-c540-47ba-9128-c8b2986ed13c"
      id="F_86c79b6a-cbed-41d2-b469-2a7018062a79">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
